Further, two studies with fixed-effects model showed the expression of B7-H3 was associated with 72-month overall survival in CRC patients (Fixed-effects, OR = 0.61, 95% CI: 0.43–0.85, P< 0.01) (Fig.3). Here, CD276 is linked to colorectal carcinoma.